Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Allergy and Asthma Proceedings|October 28, 2020
Hereditary angioedema: Long-term prophylactic treatmentHuamin Henry LiPatient Preference and Adherence|September 24, 2016
Self-administered C1 esterase inhibitor concentrates for the management of hereditary angioedema: usability and patient acceptanceHuamin Henry LiAllergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|March 23, 2019
Indirect comparison of intravenous vs. subcutaneous C1-inhibitor placebo-controlled trials for routine prevention of hereditary angioedema attacksJonathan A Bernstein, Huamin Henry Li, Timothy J Craig, et al.Proceedings of the National Academy of Sciences of the United States of America|July 2, 2025
Vamp3/syntaxin 4 mediates the basolateral membrane fusion of TfR transcytosis across the BBB and is exploited by pathogenic E. coliBin Liu, Yingying Su, Hao Sun, et al.The Journal of Allergy and Clinical Immunology. in Practice|November 8, 2016
Subcutaneous Icatibant for the Treatment of Hereditary Angioedema Attacks: Comparison of Home Self-Administration with Administration at a Medical FacilityIris M Otani, William R Lumry, Shelley Hurwitz, et al.Allergy and Asthma Proceedings|April 20, 2018
Hereditary angioedema from the patient's perspective: A follow-up patient surveyAleena Banerji, Yu Li, Paula Busse, et al.Advances in Therapy|June 10, 2026
Long-Term Integrated Safety and Efficacy of Garadacimab for Hereditary Angioedema ProphylaxisTimothy J Craig, Mar Guilarte, Huamin Henry Li, et al.Pageof 1